Precigen
Commercializes PAPZIMEOS while developing selected gene and cell therapies.
$6.97
After-hours close+0.04 (+0.50%)
At close$6.94(−3.55%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 40.11%142.98M sharesInsiders 2.98%10.64M sharesOther 56.91%202.89M shares
Shares outstanding 356.51M · Float 159.28M · 44.7% free float
Institutions13F, as of Jun 30, 2026
225 holders · 142.98M shares · 40 new positions · 125 increased · 47 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Patient Capital Management, LLC | 19.04M | 5.34% | +1.22M | Aug 13, 2026 |
| BlackRock, Inc. | 17.15M | 4.81% | +1.92M | Aug 7, 2026 |
| State Street Corp | 12.00M | 3.37% | +1.11M | Aug 7, 2026 |
| Diametric Capital, LP | 9.27M | 2.60% | +2.47M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.91M | 2.22% | +757.2K | Aug 13, 2026 |
| Tang Capital Management LLC | 6.42M | 1.80% | 0 | Aug 14, 2026 |
| Boxer Capital Management, LLC | 5.15M | 1.44% | +1.65M | Aug 14, 2026 |
| Geode Capital Management, LLC | 5.02M | 1.41% | +405.6K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Randal J. Kirkincl. Third Security, LLC, R.J. Kirk Declaration of Trust | 35.90% | 133.96M | 13D | Mar 31, 2026 ↗ |
| Patient Capital Management, LLC | 10.20% | 36.01M | 13G | Feb 13, 2026 ↗ |
| William H. Miller III Living Trust dated April 17, 2017 | 9.20% | 34.05M | 13G | Sep 23, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Helen Sabzevari | officer: President and CEO | 3.78M | 1.06% | Aug 25, 2026 |
| Fred Hassan | director | 1.24M | 0.35% | Mar 16, 2026 |
| Steven Frank | director | 1.23M | 0.34% | Mar 16, 2026 |
| Cesar L. Alvarez | director | 782.9K | 0.22% | Mar 16, 2026 |
| Donald P. Lehr | officer: Chief Legal Officer | 758.2K | 0.21% | Aug 25, 2026 |
| James S. Turley | director | 685.4K | 0.19% | Mar 16, 2026 |
| Vinita D. Gupta | director | 666.0K | 0.19% | Mar 16, 2026 |
| Rutul R. Shah | officer: Chief Operating Officer | 468.9K | 0.13% | Aug 25, 2026 |
| Nancy H. Agee | director | 309.2K | 0.09% | Aug 25, 2026 |
| Randal J. Kirk | director, 10 percent owner: | 302.2K | 0.08% | Mar 31, 2026 |
1 ten-percent owner holds 20.65M shares by Form 4, outside the officers-and-directors figure above · 19 people have not refiled in the last 18 months (2.87M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jeffrey B. Kindlerdirector | Sale | 185,000 | $7.44 | 17,100 |
| Aug 21, 2026 | Nancy H. Ageedirector | Purchase | 3,411 | $7.23 | 309,187 |
| Aug 25, 2026 | Phil Tennantofficer: Chief Commercial Officer | Sale | 79,166 | $7.50 | 141,992 |
| Aug 25, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 15,342 | $7.50 | 468,865 |
| Aug 21, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 34,658 | $7.50 | 465,012 |
| Aug 6, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 32,739 | $6.86 | 465,012 |
| Aug 3, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 33,772 | $6.50 | 497,751 |
| Jul 31, 2026 | Harry Jr. Thomasianofficer: Chief Financial Officer | Sale | 100,000 | $6.06 | 254,535 |
| Jun 29, 2026 | Helen Sabzevariofficer: President and CEO | Sale | 346,836 | $5.89 | 3,768,872 |
| Jun 29, 2026 | Rutul R. Shahofficer: Chief Operating Officer | Sale | 42,924 | $5.85 | 497,751 |
CongressHouse and Senate disclosures
Not reported.